Fharmacy Bazaar Limited
About Fharmacy Bazaar Limited
Data last updated: 11 January 2026
Fharmacy Bazaar Limited is a public limited company based in Kolkata, West Bengal, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 07 April 1992, the company has been in operation for over 34 years.
Registered with ROC Kolkata under CIN U51109WB1992PTC055160.
Capital: an authorised share capital of ₹16 Cr and a paid-up capital of ₹10 Cr. Formerly known as Krishma Exports (India) Ltd. It is led by directors including Malti Jaiswal and Sayantani Dey Sarkar.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Kolkata, West Bengal.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.29 Cr, a growth of 149% compared to the previous year.
The company is associated with 1 brand - Krishma Exports. As per MCA filings, the company has open charges of ₹16.75 Cr and satisfied charges of ₹22.6 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered Address1 St Floor, 1/175 Gariahat Road, Kolkata, West Bengal, India – 700068
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Fharmacy Bazaar Limited
Fharmacy Bazaar Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U47721WB1992PLC055160, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U47721WB1992PLC055160 | Current |
| U51109WB1992PTC055160 | Previous |
| U51109WB1992PLC055160 | Previous |
Associated Brands with Fharmacy Bazaar Limited
Fharmacy Bazaar Limited operates one associated brand: Krishma Exports. These brands represent Fharmacy Bazaar Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports a wide range of pharmaceutical products, including tablets and capsules. | krishmapharma.com |
Competitors & Alternatives of Fharmacy Bazaar Limited
Brands and companies operating in the same space as Fharmacy Bazaar Limited include Entero Healthcare, AmerisourceBergen, Keimed and 3 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Entero Healthcare
|
India's leading healthcare products distribution platform | Mumbai, India, India | 2018 |
AmerisourceBergen
|
Pharmaceutical distribution and supply chain services are provided globally. | Chesterbrook, United States, United States | 1985 |
Keimed
|
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | Hyderabad, India, India | 2000 |
Sandor Medicaids
|
Provider of medical equipment, devices, and drugs distribution services | Hyderabad, India, India | 1995 |
Dipna Pharmachem
|
Distributor of pharmaceutical raw materials | Ahmedabad, India, India | 2011 |
Mahaveer Medi Sales
|
Serves as a distributor of a wide range of pharmaceutical drugs. | Bengaluru, India, India | 2016 |
Business Activity of Fharmacy Bazaar Limited
Fharmacy Bazaar Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | ********* |
Board of Directors of Fharmacy Bazaar Limited
Fharmacy Bazaar Limited is currently managed by 6 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Malti Jaiswal | Director | 15 Feb 2025 | 1 Years 4 Months | Current |
|
Sayantani Dey Sarkar
Also directs:
Karna Spirits Limited, Bethel Medipharma Private Limited, Green Star Industries Limited and 2 more
|
Director | 06 Sep 2022 | 3 Years 10 Months | Current |
|
Vinita Saraf
Also directs:
Logica Infoway Limited, Piyush Ltd
|
Director | 01 Aug 2025 | 0 Years 11 Months | Current |
|
Paritosh Banik
Also directs:
Karna Spirits Limited
|
Director | 06 Jan 2023 | 3 Years 6 Months | Current |
|
Tapas Kumar Biswas
Also directs:
Ram Lalla Distributor Llp, Pleasure Liquors Private Limited, Green Star Commercial Private Limited and 3 more
|
Managing Director | 08 Jan 2021 | 5 Years 6 Months | Current |
Financials of Fharmacy Bazaar Limited FY 2024 filings available
Fharmacy Bazaar Limited reported revenue of ₹67.29 Cr (up 149% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Fharmacy Bazaar Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2025 | Others | ₹16 Cr | Open |
| 28 May 2024 | Indian Overseas Bank | ₹6.6 Lakh | Open |
| 06 Jul 2023 | Hdfc Bank Limited | ₹6.81 Lakh | Open |
| 03 Feb 2023 | Tata Capital Financial Services Limited | ₹10.09 Lakh | Open |
| 31 Jan 2023 | Tata Capital Financial Services Limited | ₹43.42 Lakh | Open |
Total charge records: 12 View all charges
Employees and EPFO Compliance at Fharmacy Bazaar Limited
View historical data on people associated with Fharmacy Bazaar Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Fharmacy Bazaar Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Fharmacy Bazaar Limited
GSTIN & GST Filing Data of Fharmacy Bazaar Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Fharmacy Bazaar Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Fharmacy Bazaar Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Fharmacy Bazaar Limited
MSME Payment Delays by Fharmacy Bazaar Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Fharmacy Bazaar Limited
Subsidiaries & Group Companies of Fharmacy Bazaar Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Fharmacy Bazaar Limited with ownership details.
MCA Filings & Documents of Fharmacy Bazaar Limited
MCA Filings & Documents of Fharmacy Bazaar Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Fharmacy Bazaar Limited
Frequently Asked Questions about Fharmacy Bazaar Limited
Fharmacy Bazaar Limited is an active public limited company in the pharma sector based in Kolkata, West Bengal, India. It was incorporated on 07 April 1992 (34+ years old) and is registered under CIN U47721WB1992PLC055160.
Fharmacy Bazaar Limited reported revenue of ₹67.29 Cr for FY 2025 (up 149.00% YoY).
The current directors of Fharmacy Bazaar Limited are:
The primary industry of Fharmacy Bazaar Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Fharmacy Bazaar Limited can be reached at the registered office: 1 St Floor, 1175 Gariahat Road, Kolkata, West Bengal, India – 700068.
The authorised capital is ₹16 Cr, and the paid-up capital is ₹10 Cr.